Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Sexually Transmitted Diseases Therapeutics Market Research Reports

Titlepublishedprice

Human Papillomavirus (HPV) - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... t covers the therapeutics market revenue; average cost of therapy, treatment practice and Human Papillomavirus (HPV) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast......"
01-Nov-2016$4950

Genital Herpes - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... therapeutics market revenue; average cost of therapy, treatment practice and Genital Herpes forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Geni......"
01-Nov-2016$4950

Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... Genital Warts (Condylomata Acuminata) Report is to understand the market and pipeline status of the drugs around the Genital Warts (Condylomata Acuminata) to explore the generic development opportunities, licensing opportunities and to gain competit......"
01-Nov-2016$2000

Chancroid-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... rstand the market and pipeline status of the drugs around the Chancroid to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides t......"
01-Nov-2016$2000

Chancroid-API Insights, 2016

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Nov-2016$1250

Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... is to understand the market and pipeline status of the drugs around the Genital Herpes to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Re......"
01-Nov-2016$2000

Gonorrhea-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... rstand the market and pipeline status of the drugs around the Gonorrhea to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides t......"
01-Nov-2016$2000

Syphilis  - Epidemiology Forecast To 2023

By Delve Insight
"...... egmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Syphilis . The report is built using data and information sourced from ......"
01-Nov-2016$2750

Genital Herpes-Pipeline Insights, 2016

By Delve Insight
"...... , Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations de......"
01-Nov-2016$1250

Genital Warts (Condylomata Acuminata)-Pipeline Insights, 2016

By Delve Insight
"...... lopment including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fu......"
01-Nov-2016$1250

Avail upto 50% Discount on below Publisher Reports.